The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild type colorectal cancer patients receiving irinotecan/cetuximab

被引：0

作者：

Puzzoni, M. ^{[1
]}

Demurtas, L. ^{[1
]}

Giampieri, R. ^{[2
]}

Ziranu, P. ^{[1
]}

Pusceddu, V. ^{[1
]}

Mandolesi, A. ^{[3
]}

Cremolini, C. ^{[4
]}

Masi, G. ^{[4
]}

Gelsomino, F. ^{[5
]}

Antoniotti, C. ^{[4
]}

Loretelli, C. ^{[6
]}

Meriggi, F. ^{[7
]}

Zaniboni, A. ^{[7
]}

Falcone, A. ^{[4
]}

Cascinu, S. ^{[8
]}

Scartozzi, M. ^{[1
]}

机构：

[1] Univ Cagliari, Oncol Med, Cagliari, Italy

[2] Polytech Univ Marche Reg, Univ Hosp, Med Oncol, Ancona, Italy

[3] AO Osped Riuniti UNIVPM, Inst Pathol, Ancona, Italy

[4] Azienda Osped Univ Pisana, Polo Oncol, Pisa, Italy

[5] Univ Modena & Reggio Emilia, Dept Oncol Haematol, Modena Canc Ctr, Modena, Italy

[6] Polytech Univ Marche Reg, Univ Hosp Marche Reg, Med Oncol, Univ Hosp, Ancona, Italy

[7] Fdn Poliambulanza, Med Oncol Unit, Brescia, Italy

[8] Univ Modena & Reggio Emilia, Modena Canc Ctr, Dept Oncol Haematol, Modena, Italy

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A22

引用

页数：2

共 50 条

[1] The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
Laura Demurtas
Marco Puzzoni
Riccardo Giampieri
Pina Ziranu
Valeria Pusceddu
Alessandra Mandolesi
Chiara Cremolini
Gianluca Masi
Fabio Gelsomino
Carlotta Antoniotti
Cristian Loretelli
Fausto Meriggi
Alberto Zaniboni
Alfredo Falcone
Stefano Cascinu
Mario Scartozzi
British Journal of Cancer, 2017, 117 : 315 - 321
[2] The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
Demurtas, Laura
Puzzoni, Marco
Giampieri, Riccardo
Ziranu, Pina
Pusceddu, Valeria
Mandolesi, Alessandra
Cremolini, Chiara
Masi, Gianluca
Gelsomino, Fabio
Antoniotti, Carlotta
Loretelli, Cristian
Meriggi, Fausto
Zaniboni, Alberto
Falcone, Alfredo
Cascinu, Stefano
Scartozzi, Mario
BRITISH JOURNAL OF CANCER, 2017, 117 (03) : 315 - 321
[3] The role of sidedness, EGFR gene copy number (GCN) and EGFR promoter methylation in RAS/BRAF wild type (WT) colorectal cancer (CRC) patients receiving irinotecan/cetuximab.
Puzzoni, Marco
Giampieri, Riccardo
Demurtas, Laura
Pusceddu, Valeria
Mandolesi, Alessandra
Faloppi, Luca
Loretelli, Cristian
Zaniboni, Alberto
Falcone, Alfredo
Cascinu, Stefano
Scartozzi, Mario
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[4] EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer
Algars, Annika
Sundstrom, Jari
Lintunen, Minnamaija
Jokilehto, Terhi
Kytola, Soili
Kaare, Milja
Vainionpaa, Reetta
Orpana, Arto
Osterlund, Pia
Ristimaki, Ari
Carpen, Olli
Ristamaki, Raija
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 922 - 929
[5] EGFR gene copy number to predict response to anti-EGFR treatment and survival in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer
Carpen, Olli
Algars, Annika
Sundstrom, Jari
Kytola, Soili
Osterlund, Pia
Lintunen, Minnamaija
Jokilehto, Terhi
Kaare, Milja
Orpana, Arto
Vainionpaa, Reetta
Ristimaki, Ari
Ristamaki, Raija
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[6] P 53 abnormal expression might influence global outcome through EGFR modulation in RAS/BRAF wild type metastatic colorectal cancer patients receiving later-line irinotecan cetuximab
Puzzoni, M.
Demurtas, L.
Ziranu, P.
Lai, E.
Giampieri, R.
Faloppi, L.
Mandolesi, A.
Cremolini, C.
Masi, G.
Gelsomino, F.
Mariani, S.
Cubeddu, A.
Casula, L.
Liscia, N.
Pusceddu, V.
Antoniotti, C.
Loretelli, C.
Meriggi, F.
Zaniboni, A.
Falcone, A.
Cascinu, S.
Scartozzi, M.
ANNALS OF ONCOLOGY, 2018, 29
[7] The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
Pina Ziranu
Eleonora Lai
Marta Schirripa
Marco Puzzoni
Mara Persano
Andrea Pretta
Giada Munari
Nicole Liscia
Valeria Pusceddu
Fotios Loupakis
Laura Demurtas
Michela Libertini
Stefano Mariani
Marco Migliari
Marco Dubois
Riccardo Giampieri
Giovanni Sotgiu
Angelo Paolo Dei Tos
Sara Lonardi
Alberto Zaniboni
Matteo Fassan
Mario Scartozzi
Targeted Oncology, 2021, 16 : 517 - 527
[8] The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
Ziranu, Pina
Lai, Eleonora
Schirripa, Marta
Puzzoni, Marco
Persano, Mara
Pretta, Andrea
Munari, Giada
Liscia, Nicole
Pusceddu, Valeria
Loupakis, Fotios
Demurtas, Laura
Libertini, Michela
Mariani, Stefano
Migliari, Marco
Dubois, Marco
Giampieri, Riccardo
Sotgiu, Giovanni
Dei Tos, Angelo Paolo
Lonardi, Sara
Zaniboni, Alberto
Fassan, Matteo
Scartozzi, Mario
TARGETED ONCOLOGY, 2021, 16 (04) : 517 - 527
[9] Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
Scartozzi, M.
Bearzi, I.
Mandolesi, A.
Giampieri, R.
Faloppi, L.
Galizia, E.
Loupakis, F.
Zaniboni, A.
Zorzi, F.
Biscotti, T.
Labianca, R.
Falcone, A.
Cascinu, S.
BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1786 - 1790
[10] Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
M Scartozzi
I Bearzi
A Mandolesi
R Giampieri
L Faloppi
E Galizia
F Loupakis
A Zaniboni
F Zorzi
T Biscotti
R Labianca
A Falcone
S Cascinu
British Journal of Cancer, 2011, 104 : 1786 - 1790

← 1 2 3 4 5 →